Evidence-Based Project and Quality Initiative Towards Improving Decision Making and Outcomes in Prostate Cancer Bone Health at Salt Lake City VASeptember 1, 2020Prostate CancerOncology
DNA Repair Gene Variants in Patients With Prostate Cancer Achieving Durable Clinical Benefit With PARP InhibitorsSeptember 1, 2020OncologyProstate Cancer
Clinical and Dosimetric Predictors of Toxicity for Treatment of Localized Prostate Cancer Using Moderately Hypofractionated RadiotherapySeptember 1, 2020Prostate CancerOncology
A Cognitive-Behavioral Stress Management Group for Men with Urologic Cancers: Pre- and Post-COVIDSeptember 1, 2020OncologyProstate Cancer
Better continence rate gives robotic prostatectomy the edgeJuly 31, 2020Genitourinary CancerProstate CancerOncology
Genetic differences by ancestry shouldn’t impact efficacy of prostate cancer therapiesJuly 27, 2020Genitourinary CancerProstate Cancer
Hypercalcemia Is of Uncertain Significance in Patients With Advanced Adenocarcinoma of the ProstateJuly 9, 2020Prostate CancerOncology
FDA approves olaparib for certain metastatic prostate cancersMay 21, 2020Genitourinary CancerProstate CancerOncology
First PARP inhibitor approved for metastatic prostate cancerMay 19, 2020Genitourinary CancerProstate CancerOncology
Combined biopsy method improves diagnostic accuracy in prostate cancerMarch 4, 2020Genitourinary CancerProstate CancerOncology
Outcomes of Statin Use in Veterans with Prostate Cancer: A Retrospective Single-Center ExperienceSeptember 9, 2019Prostate Cancer
Men Talking to Men about Prostate Cancer—A Veteran Centered Prostate Cancer Support GroupSeptember 9, 2019Prostate Cancer
Prostate and Lung Cancer Incidence and Survival Patterns Among VeteransSeptember 6, 2019Prostate CancerLung Cancer
Genomic Medicine and Genetic Counseling in the Department of Veterans Affairs and Department of Defense (FULL)August 8, 2019OncologyBreast CancerProstate Cancer
